These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 29454676)
1. OPA1: How much do we know to approach therapy? Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676 [TBL] [Abstract][Full Text] [Related]
2. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model. Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463 [TBL] [Abstract][Full Text] [Related]
3. Eight human OPA1 isoforms, long and short: What are they for? Del Dotto V; Fogazza M; Carelli V; Rugolo M; Zanna C Biochim Biophys Acta Bioenerg; 2018 Apr; 1859(4):263-269. PubMed ID: 29382469 [TBL] [Abstract][Full Text] [Related]
5. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Zanna C; Ghelli A; Porcelli AM; Karbowski M; Youle RJ; Schimpf S; Wissinger B; Pinti M; Cossarizza A; Vidoni S; Valentino ML; Rugolo M; Carelli V Brain; 2008 Feb; 131(Pt 2):352-67. PubMed ID: 18222991 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency. Kushnareva Y; Seong Y; Andreyev AY; Kuwana T; Kiosses WB; Votruba M; Newmeyer DD Cell Death Dis; 2016 Jul; 7(7):e2309. PubMed ID: 27468686 [TBL] [Abstract][Full Text] [Related]
7. Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy. Yu-Wai-Man P; Davies VJ; Piechota MJ; Cree LM; Votruba M; Chinnery PF Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4561-6. PubMed ID: 19443720 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809 [TBL] [Abstract][Full Text] [Related]
16. Changes in Mitochondrial Morphology and Bioenergetics in Human Lymphoblastoid Cells With Four Novel OPA1 Mutations. Kao SH; Yen MY; Wang AG; Yeh YL; Lin AL Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2269-78. PubMed ID: 25744979 [TBL] [Abstract][Full Text] [Related]
19. OPA1 haploinsufficiency due to a novel splicing variant resulting in mitochondrial dysfunction without mitochondrial DNA depletion. Sun C; Wu X; Bai HX; Wang C; Liu Z; Yang C; Lu Y; Jiang P Ophthalmic Genet; 2021 Feb; 42(1):45-52. PubMed ID: 33251885 [No Abstract] [Full Text] [Related]